Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Strontium, particularly in the form of strontium ranelate, has been investigated for its role in bone health and fracture healing. Several clinical studies and meta-analyses have demonstrated that strontium ranelate can reduce the risk of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis. Strontium works by both stimulating bone formation by osteoblasts and reducing bone resorption by osteoclasts, thereby increasing bone mineral density (BMD). Its dual mechanism differentiates it from many other osteoporosis medications, which typically focus on only one aspect of bone remodeling.

However, while there is substantial evidence for its efficacy in preventing fractures due to osteoporosis, the use of strontium for acute fracture healing or in the general support of broken bones is less well established. Most guidelines recommend strontium ranelate for patients at high risk of fractures rather than as a first-line agent for bone healing after trauma. Moreover, concerns about cardiovascular risk have limited its use in certain populations.

In summary, strontium’s use is scientifically validated primarily for osteoporosis-related fracture prevention, with moderate evidence from randomized controlled trials. Its direct application in speeding the healing of broken bones is less clear, so the evidence rating is moderate (3/5). Patients should consult healthcare professionals before using strontium, especially given possible side effects and contraindications.

More about strontium
More about Broken Bones

Other ingredients used for Broken Bones

Other health conditions supported by strontium

Products containing strontium